Vickie Y. Jo

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff et al. · Clinical Cancer Research · 2020 · 365 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo et al. · JAMA Oncology · 2020 · 347 citations · Full text

Medicine, Immunology, Oncology +17

Malignancy Risk for Fine-Needle Aspiration of Thyroid Lesions According to The Bethesda System for Reporting Thyroid Cytopathology

Vickie Y. Jo, Edward B. Stelow, Simone M. Dustin et al. · American Journal of Clinical Pathology · 2010 · 332 citations · Full text

Medicine, Oncology, Pathology +16

Clinically Relevant Molecular Subtypes in Leiomyosarcoma

Xiangqian Guo, Vickie Y. Jo, Anne M. Mills et al. · Clinical Cancer Research · 2015 · 153 citations

Medicine, Oncology, Pathology +17

Epithelioid Malignant Peripheral Nerve Sheath Tumor

Vickie Y. Jo, Christopher D.�M. Fletcher · The American Journal of Surgical Pathology · 2015 · 149 citations

Medicine, Oncology, Pathology +14